Content about Collaborative Care

September 13, 2012

The Food and Drug Administration has approved a new drug for multiple sclerosis.

CAMBRIDGE, Mass. — The Food and Drug Administration has approved a new drug for multiple sclerosis.

Sanofi subsidiary Genzyme announced that the FDA had approved Aubagio (teriflunomide) as a once-daily, oral treatment for patients with relapsing MS.

September 13, 2012

Johnson & Johnson has named a new group worldwide chairman.

NEW BRUNSWICK, N.J. — Johnson & Johnson has named a new group worldwide chairman.

The company said Sandra Peterson — who currently serves as chairman and CEO of Bayer CropScience AG, based in Europe — will have responsibility for the J&J consumer group of companies, information technology and global supply chain. She also will become a member of J&J's executive committee.

September 13, 2012

Pfizer has inked a deal with a Chinese drug maker to make branded-generic drugs for China and global markets, the companies said.

HANGZHOU, China — Pfizer has inked a deal with a Chinese drug maker to make branded-generic drugs for China and global markets, the companies said.

September 13, 2012

Prestige Brands is sprucing up its portfolio with new Luden's and Chloraseptic products.

IRVINGTON, N.Y. — Prestige Brands is sprucing up its portfolio with new Luden's and Chloraseptic products.

Luden's has introduced new Moisture Drops, which are designed to soothe the dryness and discomfort associated with dry mouths, while easing everyday throat irritations. The lozenge works with a unique "HydroAction" formula and is available in a kiwi-strawberry flavored lozenge. The new Luden's Moisture Drops are available in a 20-count bag at a suggested retail price of $1.79.

September 13, 2012

The vaccines division of French drug maker Sanofi has signed a deal with actor Chris O'Donnell to promote its flu vaccination products, the company said.

SWIFTWATER, Pa. — The vaccines division of French drug maker Sanofi has signed a deal with actor Chris O'Donnell to promote its flu vaccination products, the company said.

Sanofi Pasteur's campaign includes an effort to build awareness of influenza and vaccine options, including the company's Fluzone Intradermal vaccine, for adults through the age of 65 years. O'Donnell has appeared in such movies as "Fried Green Tomatoes" and "Kinsey," and more recently in such television shows as "NCIS: Los Angeles."

September 12, 2012

The American Academy of Pediatrics on Tuesday recommended annual trivalent seasonal influenza immunization for all individuals ages 6 months and older, including all children, adolescents and young adults.

ELK GROVE VILLAGE, Ill. — The American Academy of Pediatrics on Tuesday recommended annual trivalent seasonal influenza immunization for all individuals ages 6 months and older, including all children, adolescents and young adults.

The updated policy statement, “Recommendations for Prevention and Control of Influenza in Children, 2012-2013” published in the October 2012 issue of Pediatrics, includes guidance on vaccine formulations, dosing and administration, as well as current treatment guidance for antiviral medications.

September 12, 2012

Abbott on Wednesday launched Drive for Five, a multifaceted, disease education and men's health awareness initiative, to encourage men to take a more proactive approach to their personal health.

NEW YORK — Abbott on Wednesday launched Drive for Five, a multifaceted, disease education and men's health awareness initiative, to encourage men to take a more proactive approach to their personal health.

September 12, 2012

As part of a meta-analysis spanning 70,000 patients, a study published in the Sept. 12 issue of JAMA determined supplementation with omega-3 fish oils was not associated with a lower risk in heart disease.

CHICAGO — As part of a meta-analysis spanning 70,000 patients, a study published in the Sept. 12 issue of JAMA determined supplementation with omega-3 fish oils was not associated with a lower risk in heart disease. Lead researcher Evangelos Rizos of the University Hospital of Ioannina in Greece, concluded that omega-3 supplement recommendations may be overblown.

September 12, 2012

GlaxoSmithKline is offering a recycling program for empty inhalers at retail pharmacies in 31 cities, the drug maker said Wednesday.

NEW YORK — GlaxoSmithKline is offering a recycling program for empty inhalers at retail pharmacies in 31 cities, the drug maker said Wednesday.

The company announced its "Complete the Cycle" program for GSK respiratory inhalers, starting in October.

September 12, 2012

Some common patient complaints regarding mail-order pharmacies and their captive consumers’ lack of choice to switch to another pharmacy if they encounter poor service are highlighted in a new video released Wednesday by the National Community Pharmacists Association.

ALEXANDRIA, Va. — Some common patient complaints regarding mail-order pharmacies and their captive consumers’ lack of choice to switch to another pharmacy if they encounter poor service are highlighted in a new video released Wednesday by the National Community Pharmacists Association.

September 12, 2012

Drug maker Johnson & Johnson said Wednesday that patients applying for its HIV drug assistance program would have a more streamlined application process.

NEW BRUNSWICK, N.J. — Drug maker Johnson & Johnson said Wednesday that patients applying for its HIV drug assistance program would have a more streamlined application process.

September 12, 2012

Rite Aid is launching a six-month, nationwide health-and-wellness campaign to mark its 50 years of operation, the retail pharmacy chain said Wednesday.

CAMP HILL, Pa. — Rite Aid is launching a six-month, nationwide health-and-wellness campaign to mark its 50 years of operation, the retail pharmacy chain said Wednesday.

September 12, 2012

Drug maker Shire is seeking Food and Drug Administration approval for a new usage for a drug used to treat attention deficit hyperactivity disorder, the company said Wednesday.

PHILADELPHIA — Drug maker Shire is seeking Food and Drug Administration approval for a new usage for a drug used to treat attention deficit hyperactivity disorder, the company said Wednesday.

Shire announced that the FDA had accepted its regulatory approval application for Vyvanse (lisdexamfetamine dimesylate) capsules for maintenance treatment of ADHD in patients ages 6 to 17 years. There currently are no stimulants approved for maintenance treatment of the condition in that age group, Shire said, and the FDA said it would complete its review by April 2013.

September 12, 2012

SoloHealth on Wednesday named Tim Kiss to serve as VP marketing — a new position at SoloHealth — as the company prepares for its nationwide rollout of the SoloHealth Station consumer kiosk this fall.

 ATLANTA — SoloHealth on Wednesday named Tim Kiss to serve as VP marketing — a new position at SoloHealth — as the company prepares for its nationwide rollout of the SoloHealth Station consumer kiosk this fall. SoloHealth also named Dan Bonert to VP advertising sales, promoted Eric Hoell to VP operations and promoted Stephen Kendig to EVP and chief commercial officer.

September 12, 2012

Most advertisements for over-the-counter versions of drugs did contain significantly less information about the risks of the medication, compared with the ads for the drug prior to its transition to OTC status, according to new research sponsored by CVS Caremark.

WOONSOCKET, R.I. — Most advertisements for over-the-counter versions of drugs did contain significantly less information about the risks of the medication, compared with the ads for the drug prior to its transition to OTC status, according to new research sponsored by CVS Caremark.

The research, published in this week's issue of the Journal of the American Medical Association, identified differences between consumer-directed advertisements for drugs when they are available by prescription only, compared with when they transition to OTC.

September 11, 2012

During Tuesday morning’s Morgan Stanley Healthcare Conference in New York City, CVS Caremark president and CEO Larry Merlo expressed optimism for a strong second half of the year and confidence in retaining a large portion of the prescription volumes gained from the Walgreens-Express Scripts impasse.

NEW YORK — During Tuesday morning’s Morgan Stanley Healthcare Conference in New York City, CVS Caremark president and CEO Larry Merlo expressed optimism for a strong second half of the year and confidence in retaining a large portion of the prescription volumes gained from the Walgreens-Express Scripts impasse.

September 11, 2012

Generic drug maker Dr. Reddy's Labs has launched a generic drug for treating high blood pressure, the company said.

HYDERABAD, India — Generic drug maker Dr. Reddy's Labs has launched a generic drug for treating high blood pressure, the company said.

Dr. Reddy's announced the launch of metoprolol succinate extended-release tablets in the 25-mg, 50-mg, 100-mg and 200-mg strengths. The drug will be available in bottle counts of 100 and 500.

The drug is a generic version of AstraZeneca's Toprol-XL, branded and generic versions of which had sales of about $1.13 billion during the 12-month period that ended in June, according to IMS Health.

September 11, 2012

Louisiana pharmacist Randy Mire testified before Congress Tuesday that efforts to combat the diabetes epidemic in his home state and elsewhere would be significantly undermined if independent community pharmacies like his are forced to stop offering diabetes testing supplies as a result of Medicare’s competitive bidding program for durable medical equipment, according to a National Community Pharmacists Association release.

ALEXANDRIA, Va. — Louisiana pharmacist Randy Mire testified before Congress Tuesday that efforts to combat the diabetes epidemic in his home state and elsewhere would be significantly undermined if independent community pharmacies like his are forced to stop offering diabetes testing supplies as a result of Medicare’s competitive bidding program for durable medical equipment, according to a National Community Pharmacists Association release.

Mire appeared on behalf of NCPA before the U.S. House Small Business Subcommittee on Healthcare and Technology.

September 11, 2012

The National Association of Chain Drug Stores Foundation has appointed Matthew Burriesci as director of development.

ALEXANDRIA, Va. — The National Association of Chain Drug Stores Foundation has appointed Matthew Burriesci as director of development.  

Burriesci began his new role with the NACDS Foundation on Aug. 20 and reports directly to NACDS Foundation president Kathleen Jaeger.  

September 11, 2012

The National Community Pharmacists Association and a number of independent pharmacy entities on Monday refiled its complaint against Express Scripts concerning its acquisition of Medco, demanding either Express Scripts be compelled to "unwind their merger" or alternatively be required to divest assets acquired from Medco.

 PITTSBURGH — The National Community Pharmacists Association and a number of independent pharmacy entities on Monday refiled its complaint against Express Scripts concerning its acquisition of Medco, demanding either Express Scripts be compelled to "unwind their merger" or alternatively be required to divest assets acquired from Medco. The independent pharmacy plaintiffs are also suing for the cost of the suit as well as "such other relief as the Court may deem just and proper."

September 11, 2012

Sagent Pharmaceuticals has launched a drug used to treat complications related to chemotherapy, the drug maker said.

 SCHAUMBURG, Ill. — Sagent Pharmaceuticals has launched a drug used to treat complications related to chemotherapy, the drug maker said.

The Schaumburg, Ill.-based company announced the launch of ondansetron injection, used to prevent nausea and vomiting associated with emetogenic cancer chemotherapy and also to prevent nausea and vomiting that follows surgery.

Various versions of the drug had sales of $49 million during the 12-month period that ended in June, according to IMS Health.

September 11, 2012

Annual premiums for employer-sponsored family health coverage reached $15,745 this year, up 4% from last year, with workers on average paying $4,316 toward the cost of their coverage, according to the Kaiser Family Foundation/Health Research and Educational Trust 2012 Employer Health Benefits Survey released Tuesday.

MENLO PARK, Calif. — Annual premiums for employer-sponsored family health coverage reached $15,745 this year, up 4% from last year, with workers on average paying $4,316 toward the cost of their coverage, according to the Kaiser Family Foundation/Health Research and Educational Trust 2012 Employer Health Benefits Survey released Tuesday. 

September 11, 2012

Drug maker Upsher-Smith Labs has introduced a new product to its prenatal vitamin line, the company said Tuesday.

 MAPLE GROVE, Minn. — Drug maker Upsher-Smith Labs has introduced a new product to its prenatal vitamin line, the company said Tuesday.

The drug maker announced the launch of Nexa Plus capsules, a once-daily, prescription vitamin that contains 350 mg of life's DHA, a plant-based and fish-free omega-3 fatty acid; 1.25 mg of folic acid; and 250 mcg of the B vitamin biotin.

September 10, 2012

A line of kid-friendly health and allergy alert accessories has expanded to include a new product.

MONTVALE, N.J. — A line of kid-friendly health and allergy alert accessories has expanded to include a new product.

September 10, 2012

A drug maker and medical research institute will work together to identify new treatments for bacterial and viral infections.

CAMBRIDGE, Mass. — A drug maker and medical research institute will work together to identify new treatments for bacterial and viral infections.

AstraZeneca and the Broad Institute, owned jointly by Harvard University and MIT, announced Monday that they would collaborate for two years to develop medicines to treat severe infections, saying the identification of high-quality chemicals for the development of new drugs was a significant challenge. The two will use the Broad Institute's collection of 100,000 chemicals known as diversity-oriented synthesis, or DOS compounds.